The Francis Crick Institute at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

The Francis Crick Institute takes part in 5 sessions at ESMO 2026 in Madrid. Its program centres on the biology behind new cancer targets and prevention, from extrachromosomal DNA to clonal blood-cell changes found inside tumours. It also asks whether blocking the inflammatory signal IL-1β, first studied for preventing heart disease, could help prevent cancer.

OrganizationESMO 2026 Attendance
The Francis Crick Institute
London, United Kingdom
crick.ac.uk
University & institute
Biomedical research institute in London, United Kingdom, founded by research funders and universities, with cancer biology among its research areas.
Abstract
Sat Oct 24
15:57–16:07
Invited Discussant 1002O and 1003O
Proffered paper: Developmental therapeutics
Talk
Sat Oct 24
16:30–16:50
Tumour infiltrating clonal haematopoiesis
Updates on myeloid neoplasms with a focus on medical oncology practice
Haematological malignancies
Abstract
Sun Oct 25
14:45–14:55
Talk
Mon Oct 26
08:30–08:45
Extrachromosomal DNA and clinical implications
New targets and strategies
Talk
Mon Oct 26
09:10–09:30
Targeting IL-1β: From cardiovascular prevention to cancer prevention?
ESMO-ESC: Joining forces - Shared mechanisms and opportunities for cardiovascular and cancer prevention

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from The Francis Crick Institute

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction